Version October 2024
| Long standing disease (>5 years) |
| Limited cutaneous disease |
| Telangiectasia |
| DLCO <60 percent predicted |
| FVC percent/DLCO percent >1.6 |
| Anti-centromere antibody |
| Anti-nucleolar pattern ANA |
| Anti-U1 RNP antibody |
| Absence of anti-Scl 70 antibody |
| Older age at onset of scleroderma |
| Elevated N-terminal pro BNP |
Do you want to add Medilib to your home screen?
